Gain Therapeutics, INC Form 4 insider transactions

CEO Matthias Alder reports transactions involving restricted stock units and common stock of Gain Therapeutics.

Gianluca Fuggetta, a Principal Accounting and Financial Officer at Gain Therapeutics, acquired 50,000 employee stock options on March 21, 2024.

Matthias Alder, CEO of Gain Therapeutics, Inc., reports the acquisition of 370,000 employee stock options.